LONDON (Alliance News) - Healthcare giant GlaxoSmithKline PLC Wednesday said a group of executives, including Chief Executive Officer Andrew Witty, acquired shares under the ShareReward Plan at a price of 1598.59 pence per share Tuesday.<br /><br />Details are as follows.<br /><br /> <table Read More
LONDON (Alliance News) - <strong>J Sainsbury</strong> Wednesday reported another drop in like-for-like sales, its second consecutive quarterly decline after nine years of unbroken sales growth. <br /><br />The UK's third-largest supermarket chain by market share posted a 1.1% decline in like-f Read More
LONDON (Alliance News) - GlaxoSmithKline PLC and Theravance Inc Wednesday announced positive results for two late stage studies of Incruse Ellipta when combined with Relvar Breo Ellipta for the treatment of chronic obstructive pulmonary disease. The two phase III studies using the combined Read More
LONDON (Alliance News) - GlaxoSmithKline PLC Monday said K Slaoui, connected person of divisional chairman Moncef Slaoui, bought 4 American Depositary Shares under the GSK 401K plan at a price of USD53.70 per ADS. Glaxo ADR shares were up 0.4% at USD53.92 Monday afternoon. By Rowena H Read More
LONDON (Alliance News) - GlaxoSmithKline PLC said Thursday that it has begun a phase III study to evaluate its Iosmapimod drug in patients with acute coronary syndrome. The study will evaluate whether the drug can reduce the risk of cardiac events such as heart attacks when administered twi Read More
LONDON (Alliance News) - The European Central Bank on Thursday cut its key interest rate to a record low and embraced a negative deposit rate, the first for a leading central bank, as it tries to fight the low inflation that is threatening to derail the euro area's fragile economic recovery.<b Read More
LONDON (Alliance News) - The following is a summary of top news stories Thursday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br />UK pharmaceutical giant<strong> GlaxoSmithKline</strong> PLC has agreed to a USD105 million settlement covering 44 US states over allegations t Read More
LONDON (Alliance News) - <strong>ASOS</strong> is dragging down the AIM All-Share Index at the open Thursday after lowering its profit guidance. The online fashion retailer, by far the biggest AIM stock by market capitalisation, dropped 40% at the open and was down 34% a half hour into trading Read More
LONDON (Alliance News) - UK pharmaceutical giant GlaxoSmithKline PLC has agreed to a USD105 million settlement covering 44 US states over allegations that it unlawfully promoted its asthma treatment Advair and antidepressants Paxil and Wellburtin. As part of the settlement, announced on Wed Read More
LONDON (Alliance News) - UK pharmaceutical giant GlaxoSmithKline PLC has agreed to a USD105 million settlement covering 44 US states over allegations that it unlawfully promoted its asthma treatment Advair and antidepressants Paxil and Wellburtin. As part of the settlement, announced on Wed Read More
LONDON (Alliance News) - The FTSE 100 started the month on the front foot Monday, closing higher, after a gauge of China's factory activity rose to a five-month high in May, suggesting the world's second-largest economy is stabilising after a subdued start to the year.<br /><br />China's offic Read More
LONDON (Alliance News) - <strong>GlaxoSmithKline</strong> has signed a collaboration and licensing agreement with UK-based biotechnology company Adaptimmune Ltd for its cancer programme, a move that comes just weeks after it agreed to sell its own cancer drug business to Novartis as part of a Read More
LONDON (Alliance News) - UK based biotechnology company Adaptimmune Ltd confirmed Monday that it had entered into a collaboration and licensing agreement with pharmaceutical giant GlaxoSmithKline PLC worth a potential USD350 million over the next seven years, for its cancer programme. Under Read More
LONDON (Alliance News) - UK based biotechnology company Adaptimmune Ltd confirmed Monday that it had entered into a collaboration and licensing agreement with pharmaceutical giant GlaxoSmithKline PLC worth a potential USD350 million over the next seven years, for its cancer programme. Under Read More
LONDON (Alliance News) - The following is a summary of top news stories Monday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br /><strong>Lloyds Banking</strong> Group PLC has given TSB GBP450 million as part of its stock market floatation, the Daily Telegraph reported on Sa Read More
LONDON (Alliance News) - UK shares have opened slightly higher Monday on a good manufacturing PMI reading from China at the weekend and ahead of Thursday's European Central Bank meeting.<br /><br />Goldman Sachs likes the shares of UK estate agents, raising <strong>Countrywide</strong> to Buy Read More
LONDON (Alliance News) - GlaxoSmithKline PLC has completed a deal to develop new cancer drugs with a UK biotech company, which could be worth over USD350 million, the Financial Times reports Monday, quoting Adaptimmune Ltd Chief Executive James Noble. Glaxo is expected to announce a deal on Read More
LONDON (Alliance News) - Polymer products manufacturer <strong>Fenner</strong> saw its shares plummet Friday, after it issued a profit warning that it blamed on a further deterioration in trading in the US and the loss of a profitable contract in Australia.<br /><br />It is the biggest faller Read More
LONDON (Alliance News) - The following is a summary of top news stories Friday.<br />----------<br /><strong>COMPANIES</strong><br />----------<br />Polymer products manufacturer <strong>Fenner</strong> PLC said underlying pretax profit for the year will be 10% to 15% below the prevailing mark Read More
LONDON (Alliance News) - UK shares have opened flat Friday, with European markets on hold ahead of a key European Central Bank meeting next week.<br /><br />FTSE 250 polymer products maker <strong>Fenner</strong> PLC said underlying pretax profit for the year to August 31 could fall by 10% to Read More